PRNewsWire - Health

Hemispherian receives positive opinion for Orphan Medicinal Product Designation in the EU for GLIX1 in glioma
HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas
HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid
YolTech Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for YOLT-101, an In Vivo Base Editing Therapy to Treat Heterozygous Familial Hypercholesterolemia (HeFH)